See also this year's filing and all EDGAR filings for this company.
PDF Report 0001369786_2012_Sagent_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001369786, Sagent Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 200,846,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 5,426,000 |
| 2 | PropertyPlantAndEquipmentNet | 884,000 |
| 3 | remainder_Assets | 23,352,000 |
| 4 | LiabilitiesCurrent | 84,142,000 |
| 5 | LiabilitiesNoncurrent | 4,697,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 25,148,000 |
| 9 | ResearchAndDevelopmentExpense | 12,763,000 |
| 10 | remainder_Expenses | 141,200,000 |
| 11 | remainder_Revenues | 152,405,000 |
| 12 | remainder_NetIncome | 284,000 |
| 13 | remainder_ComprehensiveNetIncome | 877,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 230,508,000 |
| 1 | Liabilities | 88,839,000 |
| 2 | Expenses | 179,111,000 |
| 3 | Revenues | 152,405,000 |
| 4 | StockholdersEquity | 141,669,000 |
| 5 | NetIncome | -26,422,000 |
| 6 | ComprehensiveNetIncome | -25,983,500 |
| 7 | BaseVar | 326,012,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.77 |
| 9 | EconomicCapitalRatio | 2.87 |
Edgar->Model Mapping
Feature Distribution
